Comparative effectiveness of fiberoptic phototherapy for hyperbilirubinemia in term infants
HAYES, Inc
Record ID 32017000368
English
Authors' recommendations:
Phototherapy is used to treat jaundice in newborns, and to prevent severe hyperbilirubinemia, and its complications. The lights in phototherapy units emit photons that alter the structure of the bilirubin molecule, which can then be excreted in bile or urine. Fiberoptic phototherapy (FPT) systems are light-emitting pads or blankets that are placed under or wrapped around an infant as an adjunct or alternative to standard phototherapy (SPT) delivered by overhead lights.
Relevant Questions: How does FPT compare with SPT for the treatment of hyperbilirubinemia in term infants?
Is FPT an effective adjunct to SPT for the treatment of hyperbilirubinemia in term infants?
Is FPT safe in term infants?
Have definitive patient selection criteria been established for the use of FPT?
Details
Project Status:
Completed
Year Published:
2017
URL for published report:
The report may be purchased from:
http://www.hayesinc.com/hayes/crd/?crd=40566
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Humans
- Hyperbilirubinemia
- Jaundice
- Phototherapy
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.